Downes, Charlotte E. J. http://orcid.org/0000-0001-7458-836X
McClure, Barbara J. http://orcid.org/0000-0002-5201-4127
Bruning, John B. http://orcid.org/0000-0002-6919-1824
Page, Elyse http://orcid.org/0000-0002-8990-2574
Breen, James
Rehn, Jacqueline http://orcid.org/0000-0001-5043-6943
Yeung, David T.
White, Deborah L. http://orcid.org/0000-0003-4844-333X
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (APP1057746, APP1057746, APP1044884)
Leukaemia Foundation
Bristol-Myers Squibb
Australian Genomics Health Alliance (AGHA) Beat Cancer
Contributing Haematologist Committee
Article History
Received: 25 March 2021
Accepted: 20 July 2021
First Online: 10 August 2021
Competing interests
: D.L.W. receives research support from BMS, Honoraria from BMS and Amgen. D.T.Y. receives research support from Novartis, Ariad and BMS, Honoraria from Novartis, BMS, Amgen and Pfizer. None of these agencies have had a role in the preparation of this manuscript. The remaining authors declare no competing interests.